<?xml version="1.0" encoding="UTF-8"?>
<ref id="B31-pathogens-08-00144">
 <label>31.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Hitoshi</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Goto</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Yamamura</surname>
    <given-names>J.I.</given-names>
   </name>
   <name>
    <surname>Kurokawa</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Kageyama</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Takahara</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Watanabe</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Shiraki</surname>
    <given-names>K.</given-names>
   </name>
  </person-group>
  <article-title>Therapeutic Basis of Glycyrrhizin on Chronic Hepatitis B</article-title>
  <source>Antiviral Res.</source>
  <year>1996</year>
  <volume>30</volume>
  <fpage>171</fpage>
  <lpage>177</lpage>
  <pub-id pub-id-type="pmid">8783808</pub-id>
 </element-citation>
</ref>
